STEVANATO GROUP S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.54 USD | +0.07% |
|
+3.03% | +0.92% |
| 22/04 | BNP Paribas Exane Initiates Stevanato Group With Outperform Rating | MT |
| 04/04 | Stevanato Group Names Ugo Gay as Chief Operations Officer | MT |
Chart calendar Stevanato Group S.p.A.
1a189f5d80cb85d1da3f30ce70.-fbNJw-hFmqv5-4LnqCgELoW3hCrqN4cvD10Sg8KqEc.ib2pFmWReTrJlrFqqcjzQPlQrWrThZ1K70xGH2ZexQ2Ms5dWV_NvNZa31g~57e7c8660d81404381cee2081e2699ce
Upcoming events on Stevanato Group S.p.A.
Past events on Stevanato Group S.p.A.
| 19/03/2024 11:00 pm | KeyBanc Life Sciences & MedTech Forum |
| 07/03/2024 07:00 pm | Q4 2023 Earnings Call |
| 07/03/2024 05:00 pm | Q4 2023 Earnings Release |
| 10/01/2024 09:45 pm | JPMorgan Healthcare Conference |
| 15/11/2023 03:30 pm | Jefferies London Healthcare Conference |
| 31/10/2023 06:00 pm | Q3 2023 Earnings Call |
| 31/10/2023 04:00 pm | Q3 2023 Earnings Release |
| 04/10/2023 07:30 pm | Extraordinary Shareholders Meeting |
| 27/09/2023 08:30 pm | Capital Markets Day |
| 28/07/2023 06:00 pm | Q2 2023 Earnings Call |
| 28/07/2023 04:00 pm | Q2 2023 Earnings Release |
| 08/06/2023 11:00 pm | Jefferies Global Healthcare Conference |
| 07/06/2023 12:50 am | William Blair Growth Stock Conference |
| 24/05/2023 07:30 pm | Extraordinary Shareholders Meeting |
| 09/05/2023 09:50 pm | Bank of America Healthcare Conference |
| 04/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 04/05/2023 04:00 pm | Q1 2023 Earnings Release |
| 21/03/2023 08:45 pm | KeyBanc Life Sciences & MedTech Forum |
| 02/03/2023 07:00 pm | Q4 2022 Earnings Call |
| 02/03/2023 05:00 pm | Q4 2022 Earnings Release |
Past dividends on Stevanato Group S.p.A.
| 07/06/2023 | Annual 0.054 EUR |
| 13/06/2022 | Annual 0.051 EUR |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 | 844 832 1.45% | 984 964 2.06% | 1 085 1 091 -0.52% | 1 195 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | 218 215 1.66% | 264 257 2.64% | 292 295 -1.19% | 321 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | 162 156 3.59% | 199 189 5.09% | 213 215 -0.84% | 230 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 166 147 12.83% | 188 177 6.1% | 190 198 -4.09% | 210 |
|
Net income Million EUR | Released Forecast Spread | 78,5 | 134 117 15.04% | 143 135 5.86% | 146 149 -2.44% | 161 |
|
EPS USD | Released Forecast Spread | 1,07 | 0,58 0,52 9.89% | 0,57 0,54 5.14% | 0,60 0,61 -2.09% | 0,65 |
| Announcement Date | 30/04/21 | 08/03/22 | 02/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 233 221 5.45% | 212 212 -0.06% | 234 229 2.48% | 245 246 -0.45% | 292 272 7.43% | 238 234 1.67% | 255 251 1.89% | 271 280 -3.2% | 321 327 -1.91% | 237 | 277 | 308 | 362 | 270 |
|
EBITDA Million EUR | Released Forecast Spread | 58,9 56,8 3.74% | 54,0 52,5 2.89% | 61,8 59,1 4.6% | 65,8 66,0 -0.28% | 81,9 74,4 10.01% | 61,9 59,7 3.62% | 68,2 66,9 1.96% | 74,7 75,5 -1.01% | 86,7 90,2 -3.86% | 62,2 | 72,7 | 85,2 | 99,2 | 71,9 |
|
EBIT Million EUR | Released Forecast Spread | 43,8 40,1 9.33% | 38,8 36,3 6.84% | 45,9 41,7 10.03% | 49,1 48,1 2.1% | 64,8 55,9 15.93% | 43,6 41,7 4.51% | 48,7 47,9 1.61% | 54,2 54,6 -0.82% | 66,6 68,4 -2.65% | 40,8 | 49,8 | 61,2 | 74,9 | 50,5 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 53,7 36,8 45.99% | 36,3 36,4 -0.19% | 41,5 39,8 4.29% | 46,0 45,2 1.84% | 63,8 52,7 21.07% | 36,0 38,3 -6.01% | 44,3 41,1 7.79% | 50,4 52,0 -3.01% | 58,8 62,9 -6.57% | 32,8 | 45,1 | 56,5 | 71,0 | 43,4 |
|
Net income Million EUR | Released Forecast Spread | 44,6 26,9 65.73% | 27,8 27,0 2.78% | 30,6 30,3 0.99% | 36,3 34,8 4.39% | 48,3 40,8 18.28% | 28,3 30,2 -6.15% | 34,3 32,5 5.51% | 37,9 40,3 -6% | 45,2 49,2 -8.08% | 28,0 | 35,1 | 43,2 | 54,1 | 36,2 |
|
EPS USD | Released Forecast Spread | 0,18 0,11 62.3% | 0,11 0,11 -2.91% | 0,12 0,12 4.92% | 0,14 0,13 7.05% | 0,19 0,16 15.86% | 0,12 0,13 -3.42% | 0,14 0,14 5.05% | 0,15 0,16 -8.98% | 0,19 0,20 -7.43% | 0,11 | 0,14 | 0,17 | 0,22 | 0,14 |
| Announcement Date | 08/03/22 | 10/05/22 | 04/08/22 | 08/11/22 | 02/03/23 | 04/05/23 | 28/07/23 | 31/10/23 | 07/03/24 | - | - | - | - | - |
More events
Past sector events for Stevanato Group S.p.A.
| 27/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 26/04/2024 03:30 pm | AVANTOR, INC.: Q1 2024 Earnings Release |
| 26/04/2024 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
| 26/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
| 26/04/2024 | SINOCARE INC.: Q4 2023 Earnings Release |
| 26/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q4 2023 Earnings Release |
| 26/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | SINOCARE INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- STVN Stock
- Calendar Stevanato Group S.p.A.
